The Preeclampsia Diagnostics Market Revenue was valued at USD 1.08 billion in 2023 and is anticipated to reach USD 1.33 billion by 2031, exhibiting a modest but steady CAGR of 2.7% during the forecast period from 2024 to 2031. The rising prevalence of preeclampsia and other hypertensive disorders in pregnancy, coupled with increasing awareness regarding early diagnosis, are key factors driving m..